Background: Foeto-placental growth is regulated by a complex balance of growth promoting and growth inhibiting factors and hormones, namely the insulin-like growth factors (IGF) and the intracellular caspase proteins. Changes in the IGF-axis appear to affect this balance, with deficiencies possibly triggering apoptosis.
INTRODUCTION
Foetal growth restriction (FGR) is a complex problem of pregnancy with many short and long term consequences. These include peri-natal morbidity and mortality, and long-term health complications, including cardiovascular disease. There are multiple aetiologies underlying this vast clinical problem, though the exact molecular mechanisms are still unknown. FGR further leads to babies being born small for their gestational ages (SGA) affecting an estimated 30 million pregnancies each year [1] . Placental, and foetal, growth regulation is a complex process controlled by genetic, environmental and hormonal factors [2] . The hormonal factors include growth hormone axes and their receptors. A key regulatory axis of normal growth is the insulin-like growth factor (IGF) hormone axis, comprised of the insulin-like growth factors (IGF-I and IGF-II), the IGF binding proteins (IGFBPS 1-6), IGFBP proteases, and the IGF-I receptor. Deficiencies, or excesses, of this axis thus affect foetal growth outcomes and viability [3] .
Cellular and tissue growth is further regulated by a balance of growth promoting and suppressing factors. Changes in this balance may therefore tip growth in either direction, as can be seen with decreases of IGF-I and IGF-II leading to SGA in pregnancy [4] . Furthermore, increases in placental apoptosis have also been seen in pregnancies affected with the clinical syndrome pre-eclampsia, which is widely associated with growth inhibition [5] . Though the exact mechanism is unknown, placental apoptosis is believed to be a key regulatory element in foetal-placental growth [6] . The two major pathways of apoptosis are the intrinsic and extrinsic pathways. The intrinsic pathway is regulated through intra-cellular mitochondrial stress with subsequent activation of the B-cell lymphoma 2 and apoptotic protease activating factor 1 (BCL-2/APAF1) pathway, leading to the nuclear activation of the caspase family of enzymes with subsequent cellular destruction. The extrinsic pathway is stimulated through cell surface tyrosine-kinase receptors with direct downstream activation of the caspase enzymes. Activation of either of these pathways triggers apoptosis leading to controlled cell and tissue death [7] .
A principal regulator of apoptosis is protein 53 (p53, pro-apoptotic), which plays a role in tumour genesis. Down regulation of the gene results in decreased apoptosis and increased cell and tissue growth [8] . Levels of p53 and the activator protein, Bcl-2, can therefore be used as markers to assess the intrinsic activation of the apoptotic cascade. In contrast, the extrinsic pathway is mediated through cell surface death receptors, leading to activation of caspase 8 [9] . Levels of caspase 8 may therefore be used as markers of the extrinsic activation of the apoptotic cascade. Aside from the regulators of apoptosis, certain key executor proteins may be seen in increased programmed cell death. Caspase 3 is one particular down-stream executioner protein of importance, as it is activated by both the intrinsic and extrinsic pathways and can be used to differentiate apoptosis from necrosis [10] .
The aim of this study was to analyse components of the apoptotic axes, namely p53, caspase 8, and caspase 3, in the placenta of babies born small and appropriate for their gestational ages (SGA and AGA, respectively), in the Pakistani and Swedish populations in an attempt to further understand the mechanisms behind foetal growth restriction.
METHODS

Population Demographics
Following informed and written consent, thirty-six placental samples were taken from two populations immediately after delivery. The samples were placed in RNAlater ® to stabilise RNA, DNA, and proteins, and subsequently frozen for further storage and transport. Categorization of samples for further analysis was done based on the respective newborn birth weights. Inclusion criteria in the AGA groups included: term delivery, normal birth weights, exclusion of any clinical diseases/syndromes, and normal progression of pregnancy. Inclusion criteria in the SGA groups included all pregnancies that had a birth weight of less than the 10 th percentile for their gestational ages ( 10 th percentile, based on population specific growth charts). Twelve Swedish samples (7 growth restricted, and 5 normal controls/appropriate for gestational age, AGA), and 24 Pakistani samples (12 growth restricted, and 12 normal controls/AGA), were included for further analysis, as described below. Population demographics are as previously described [11, 12] . Infant and maternal height, weight, and body mass index (BMI) at delivery were measured.
Cell Death ELISA
Protein extraction and quantification was conducted according to the Bradford assay (Bradford protein assay kit, Bio-Rad Laboratories, CA, USA). Cellular apoptosis was assessed by the detection and quantification of cytoplasmic histone-associated DNA fragments (mono-and oligonucleosomes) by photometric enzyme immunoassay (Cell Death Detection Kit ELISA PLUS , Roche Diagnostics Scandinavia AB). Tissue lysis was performed according to the manufacturer's protocol (20 l sample + 80 l lysis buffer). Following centrifugation, the supernatant was then removed for analysis of cytoplasmic histone-associated DNA fragments. Necrosis was excluded by the negative determination of mono-and oligonucleosomes in the protein extract from tissue samples. All samples were analysed in triplicates. Results are expressed as 'apoptotic activity', an optical absorbance ratio of the absorbance (10 -3 ) of the dead/dying cells divided by the absorbance from the corresponding positive and negative controls (enrichment factor ratio, based on manufacturer's protocol).
Immunohistochemical Staining
Prior to immunohistochemical analysis, samples were defrosted and fixed in 4% paraformaldehyde for 24 hours following which they were transferred to 70% ethanol at 4ºC. The samples were then trimmed and routinely embedded in paraffin using an automated processor, sectioned at 5 m thickness. Three sections of each sample were included on a single slide. Immunohistochemical staining for p53, caspase 8, and caspase 3, was conducted using the BOND-MAX analyser (Leica Microsystems, Germany). Endogenous peroxidase activity was quenched for 10 min at room temperature in methanol containing 1.5% hydrogen peroxide. Antigen retrieval was done in the buffer ERI (citrate-based, pH 5.9-6.1) for 20 minutes at 94°C to 96ºC. The automated analyser was then programmed to run the primary antibody for 30 minutes. The antibody DO-7 (p53; Dako Sweden AB), was used at a dilution of 1:500, the antibody AB61755 (caspase 8; Abcam PLC, UK), was used at a dilution of 1:500, and the antibody JHM62 (caspase 3; Novocastra, UK) was used at a dilution of 1:50. The sections were washed and then incubated with goat anti-rabbit immunoglobulins conjugated to peroxidase-labelled dextran polymer (Dako Sweden AB) for 15 minutes at room temperature. The peroxidase reaction was then developed with 3'3-diaminobenzidine (DAB) and counterstained with haematoxylin, for 10 minutes each, respectively (Figures 1 and 2) . Staining for each respective antibody was done as a single experiment in the BOND-MAX analyser. Positive controls were as follows: intestine (p53); testis (caspase 8); skin (caspase 3).
TUNEL Assay
To examine DNA fragmentation by apoptosis we used terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) by labelling the terminal end of nucleic acids. Placental samples were paraffin embedded and fixed as described above. Sections were treated with xylene for 10 minutes, then, gradient ethanol concentration from 100-70%, each for 5 minutes. Afterwards, samples were washed with 1XPBS and treated with 0.1% sodium citrate + 0.1%Triton X-100 in 1xPBS for 8 minutes at room temperature. In Situ Cell Death Detection Kit (Roche) was used according to the protocol provided. The samples were mounted and counterstained for 15 min in VECTASHIELD® with DAPI (Vector), and the resulting fluorescent signals were detected by fluorescence microscopy.
Image Analysis and Scoring
Ten separate fields in each of three nonadjacent sections from each sample (per slide) were examined for staining employing a Leica microscope (40 X magnification; Leica Microsystems GmBH, Wetzlar, Germany) equipped with a Sony digital video camera (Diagnostic Instruments, Inc., Sony, Japan) interfaced to a computer. For the purposes of accurate image analysis, immunostained cells were manually evaluated by two blinded observers to the groups (S.A & E.S). A quantitative manual scoring system was used counting the total number of (-) negative and (+) positive staining cells in each of the fields. Counts from both observers were then averaged and are as described as a ratio/percentage of positive cells. These results are expressed as an apoptotic index (relative ratio of the apoptotic cells to the total number of cells).
Ethical Considerations
All placental samples were obtained following ethical approval from the Northern Stockholm Ethical Committee, Stockholm, Sweden, and the Aga Khan University Ethical Review Committee, Karachi, Pakistan. Furthermore, written consent was obtained from all mothers prior to sample acquisition.
Statistical Analysis
Statistical comparisons between the groups were done using Student's t-test. Further comparisons were done using analysis of variance (ANOVA), and the Tukey's post hoc test. Statistical significance was taken as a p-value of less than 5% (p < 0.05).
RESULTS
Population Demographics
The study group consisted of samples from both the Swedish and Pakistani populations, as previously described [11] . In total, 24 Pakistani samples and 12 Swedish samples were included in the study ( Table 1) . Swedish mothers were significantly taller than the Pakistani mothers in the appropriate for gestational age (AGA) group (p < 0.01; Table 1a ). Swedish mothers were also both significantly taller and weighed more than their Pakistani counterparts in the SGA group (p < 0.01). Furthermore, differences, though not statistically significant, were seen in maternal body mass index (BMI, p = 0.06) and infant weight (p = 0.06) comparing populations in the SGA groups (Table 1b) . Maternal body mass index was also significantly lower in the mothers of the SGA group, within each respective population (p < 0.01).
Cell Death ELISA
Apoptotic activity was significantly higher in the Pakistani samples, both SGA and AGA, as compared to the Swedish placental samples (p < 0.05, Figure 3) . Further analysis showed a significantly higher level of apoptosis in the Pakistani population comparing the SGA and AGA samples (p < 0.01), and the Swedish population comparing the SGA and AGA groups (p < 0.05).
Immunohistochemical Analysis and TUNEL Assay
There were no differences in apoptotic index for p53 comparing population sub-groups, and comparing between the SGA and AGA groups. Immunohistochemical staining for p53, caspase 8, and caspase 3 can be seen in Figures 1 and 2 , showing the control group (AGA), the growth restricted group (SGA), and the positive controls, for each respective marker. Caspase 8 and caspase 3 showed significantly higher apoptotic indices in the Pakistani population (SGA and AGA groups), as compared to the Swedish population. This can be more clearly seen in Figures 4a and 4b , respectively (p < 0.01). The figures indicate higher levels of apoptosis in the Pakistani population, as well as higher levels in the SGA groups, as compared to the AGA groups, though these differences were not statistically significant. Levels of DNA fragmentation (TUNEL) were higher in the SGA groups as compared to the AGA groups, though these differences were not statistically significant (Swedish population, p = 0.16; Pakistani population, p = 0.33). Furthermore, whilst comparing between populations, levels of DNA fragmentation were higher in the Pakistani groups as compared to the Swedish groups (SGA, p = 0.06; AGA, p < 0.01; Figure 4c ).
DISCUSSION
The aims of this study were to quantify levels of placental apoptosis comparing growth outcomes in Pakistani and Swedish population sub-groups in an attempt to better understand the mechanisms of growth restriction. Furthermore, we attempted to ascertain which apoptotic pathway was triggered in the placenta by looking at key initiators of apoptosis, namely, p53, and caspase 8. Our results show increases in apoptotic activity in the placenta of babies born SGA, as well as higher levels of apoptotic activity in the placenta from the Pakistani population, as compared to the Swedish population. Furthermore, we have shown that the extrinsic pathway of apoptosis, through caspase 8 activation, appears to be the principal pathway of apoptosis in the placenta.
The difference in apoptotic activity between populations is interesting and may suggest a relationship between maternal size and levels of placental apoptotic activity in an attempt to control foetal-placental growth [13] . The smaller Pakistani mothers, on average, give birth to smaller babies, and this may, hypothetically, be a result of increased placental apoptosis. These results suggest the role of population genetics and environmental factors in birth weight outcomes, particularly that of maternal constraint. Gluckman, et al., describe maternal constraint as 'a set of poorly defined processes by which maternal and uteroplacental factors act to limit the growth of the foetus, presumably by limiting nutrient availability and/or the metabolic-hormonal drive to grow' [14] . They further associate this clinical phenomenon to smaller maternal size, as was seen in the SGA groups of both populations. Smaller mothers amount to smaller pelvis size and structure and thus cannot accommodate larger babies, possibly controlling foetal-placental growth and size. Smaller parents are also genetically more likely to have smaller children, though our results showed no differences in anthropometric parameters of babies born in the AGA groups comparing both populations, suggesting the importance of other factors beyond population genetics influencing foetal-placental growth [15] . We have also shown that placental apoptosis is principally controlled through the extrinsic pathway, through the activation of caspase 8. The significantly increased apoptotic index in the Pakistani population may indicate that these placentas have a higher baseline level of apoptosis, particularly towards the end of pregnancy. They may also indicate differences in the handling of tissues from both populations, whereby small delays in the appropriate transporting and storing of tissues influences levels of apoptosis and tissue necrosis.
Barrio, et al., amongst others, has shown significantly higher levels of caspase 3, the apoptotic executioner, in placenta of SGA babies [16, 17] . We did not, however, find any significant differences in our population groups. Furthermore, despite the lack of difference in caspase 3 positive cells in our population subgroups, we have shown significant differences in levels of DNA histone complexes in our subgroups, through the use of the apoptosis ELISA, as well as differences in DNA fragmentation through TUNEL assays. These results indicate the final products of apoptosis and suggest higher levels of apoptosis in the SGA groups as compared to the AGA groups, and in the Pakistani subgroup in comparison to the Swedish subgroup. There is little data on the direct comparison of placental apoptosis in different populations, suggesting that the significant differences we have shown in our sub-groups may in part be due to ethnic factors. As mentioned previously, comparisons of the normal control groups (AGA) between populations showed no difference, indicating that genetics may not play a significant role in the pathogenesis of FGR. We appreciate the limitations our small sample size may pose and suggest further studies be conducted to compare apoptosis across populations.
Protein 53 (p53) is a well known pro-apoptotic tumour suppressor and has been shown to promote growth arrest and cellular senescence [18] . Furthermore, it has also been shown to block angiogenesis, restricting tissue growth. Increases in p53 gene expression have been further associated with the development of gestational trophoblastic disease and trophoblastic apoptosis in association with foetal growth restriction [19, 20] . P53 may thus act as an intrinsic initiator of apoptosis in higher risk pregnancies. We did not, however, find any p53 positive cells in our subgroups, suggesting that the placental activation of apoptosis is principally regulated through the extrinsic pathway, possibly through decreased expression of growth promoting factors, as has previously been described by us [11, 21] .
The IGF-axis plays a key role in foetal-placental growth, with down-regulation resulting in increases in placental apoptosis as a possible cause for intrauterine growth restriction [22] . Furthermore, IGF-I has been previously shown to have anti-apoptotic activity through the activation of an intracellular tyrosine kinase receptor, playing a key role in cell and tissue growth and modulation [23] . We have previously shown similar results of the effects of decreased IGF-I and IGF-II mRNA expression, along with decreased IGF-I protein levels, correlating to low birth weight [21] . The increased apoptotic activity in the placenta of SGA babies, seen in our results, suggests that this increase may be secondary to the down-regulation of the IGFaxis, thereby resulting in decreased growth and subsequent growth restriction. Furthermore, this fine balance between growth promoting and suppressing factors appears to be associated with maternal anthropometry, re-emphasising the importance of establishing maternal pregnancy growth charts to aid in the timely diagnosis of intrauterine growth restriction (IUGR). This is of particular importance in areas where ethnic and environmental factors appear to play a role in the pathogenesis of this devastating clinical problem. In developing countries, such as Pakistan, where advanced radiological diagnostic tools are scarcely available, early screening and identification of high-risk pregnancies through clinical screening may allow for timely intervention. This, in turn, may help break this vicious cycle of poor growth, aiding towards a healthier population. Finally, maternal blood samples screening for biomarkers of foetal-placental growth (such as placental growth factors) may be an additional useful screening tool, globally, to help improve the diagnosis of IUGR and pregnancy related disorders affecting foetal-placental growth, such as pre-eclampsia [24] .
